After months of deliberation, and no formal offers from a buyer, Novartis has decided that its generics business Sandoz will be spun out into an independent company. The Swiss pharma group said ...

hành động để đạt được mục tiêu giảm tình trạng kháng thuốc. Theo ông Charaf Eddine Kadri, Tổng Giám đốc Sandoz Việt Nam, có một thực tế rất phổ biến ...

Generic and biosimilar drug producer Sandoz has agreed a $265 million settlement that aims to put allegations of price-fixing brought in a Pennsylvania lawsuit behind it. The agreement – which ...

(RTTNews) - Swiss generic pharmaceutical company Sandoz Group AG (SDZNY) announced on Monday that Peter Stenico has been appointed as the new President Region International and member of the ...

Strong first year as standalone company; global leader Sandoz uniquely positioned in attractive and growing USD 200 billion market for generics and biosimilars Leading in home market Europe ...